CARDIOVASCULAR RISK REDUCTION BY REVERSING ENDOTHELIAL DYSFUNCTION: ARBS, ACE INHIBITORS,  OR BOTH? EXPECTATIONS FROM THE ONTARGET  TRIAL PROGRAMME

Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors,  or both? Expectations from The ONTARGET  Trial Programme

Luis Miguel  Ruilope1, Josep Redón2, Roland Schmieder31Servicio de Nefrologia, Unidad de Hipertension Hospital, 12 de Octubre, Madrid, Spain; 2Department of Internal Medicine, Hospital Clinico University of Valencia, Valencia, Spain; 3Department of Nephrology and Hypertension, Friedrich-Alexander-Universitat, Erlangen-Nurnberg, GermanyA

read more


Designing for social interaction in high-density housing: A multiple case analysis of recently completed design-led developments in London

Over the past two decades, the Greater London Authority (GLA) has pursued the delivery of high-density development in London in order to respond to gildan cobalt population growth whilst protecting the green belt.Though high-density places have been associated with sustainable outcomes, it is well documented that residents interact less frequently

read more